Flores Legarreta, A., Eckstein, O., Burke, T. M., & McClain, K. L. (2018). Anti TNF-α therapy in patients with relapsed and refractory Langerhans cell histiocytosis: A phase II study. Pediatric Hematology & Oncology, 35(5/6), 362. https://doi.org/10.1080/08880018.2018.1539149
Chicago Style (17th ed.) CitationFlores Legarreta, Alejandra, Olive Eckstein, Thomas M. Burke, and Kenneth L. McClain. "Anti TNF-α Therapy in Patients with Relapsed and Refractory Langerhans Cell Histiocytosis: A Phase II Study." Pediatric Hematology & Oncology 35, no. 5/6 (2018): 362. https://doi.org/10.1080/08880018.2018.1539149.
MLA (9th ed.) CitationFlores Legarreta, Alejandra, et al. "Anti TNF-α Therapy in Patients with Relapsed and Refractory Langerhans Cell Histiocytosis: A Phase II Study." Pediatric Hematology & Oncology, vol. 35, no. 5/6, 2018, p. 362, https://doi.org/10.1080/08880018.2018.1539149.